Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Dr. Tess Saarel, Chairman of Pediatric Cardiology at Cleveland Clinic, discusses ventricular arrhythmias and the prevention of sudden cardiac death in children, including guideline changes, prevention of sudden cardiac death in hypertrophic cardiomyopathy patients, challenges of placing ICDs in young patients, and the use of subcutaneous ICDs. The talk was presented at the Cleveland Clinic’s 4th Annual Advances in Pediatric and Congenital Heart Summit focused on Congenitally Corrected Transposition of the Great Arteries. We look forward to the 5th Annual Advances in Congenital Heart Disease at Cleveland Clinic in October of 2020.

Samir Kapadia, MD, Chairman, Department of Cardiovascular Medicine and Amar Krishnaswamy MD, Section Head, Interventional Cardiology discuss the nuances of tricuspid valve management for healthcare providers; including the challenges of tricuspid regurgitation; optimal medical management (other valve disease, heart failure and atrial fibrillation); the role of cardiac devices in tricuspid regurgitation; and new innovations and studies involving tricuspid valve treatment. Dr. Kapadia and Dr.Krishnaswamy discuss the focus of current trials and outcome measurements, and point out important considerations in the treatment of tricuspid regurgitation

Dr. Lee Kirksey, Vascular Surgeon and Vice Chairman of Vascular Surgery talks with staff vascular surgeon Dr. David Hardy , vascular medicine specialist and director of the vascular lab, Dr. Natalia Fendrikova Mahlay and imaging/diagnostic radiology specialist Dr.Paul Schoenhagen about vascular imaging. They discuss types of services that are offered in a vascular imaging lab, how cardiovascular CT and MRI work with clinicians to help diagnose conditions and plan treatment, the integration of imaging systems allowing both health system hospitals and external hospitals to share images easily, quality initiatives, as well as imaging considerations in special populations such as aortic disease and chronic kidney disease.

Dr. Stephen Ellis, Interventional Cardiologist at Cleveland Clinic takes us through the results of the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA Trial) and provides key take-aways from the results.

Dr. Leslie Cho,Director of the Women’s Cardiovascular Center and Co-Section Head, Preventive Cardiology discusses risk factors that clinicians can look for in women to prevent future heart disease (such as pregnancy associated cardiovascular risk factors, premature menopause, polycystic ovary syndrome, and autoimmune disease). Dr. Cho discusses research based and guideline directed strategies to initiate in patients with these risk factors.

Dr. Steven Nissen, Chief Academic Officer, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular talks with Dr. Stan Hazen, Co-Section Head, Preventive Cardiology and researcher about the gut microbiome and how it relates to cardiovascular disease. Dr. Hazen provides a description of TMAO and how it is related to diet and risk of heart and vascular disease. He describes what specific bacteria is involved with this type of activity, how they are approaching future research and treatment of cardiovascular risk gut microbiome and why the Mediterranean diet may be so effective in preventing heart disease.

Dr. Steven Nissen, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute talks with Dr. Serg Harb, a staff imaging cardiologist about the innovative diagnostic tool of 3D Printing – What are the clinical uses? Limitations? Research findings and future innovation.

Dr. Steven Nissen, Chief Academic Officer, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute discusses the benefits of metabolic (also called bariatric) surgery with surgeon Ali Aminian from the Bariatric and Metabolic Institute. Dr. Aminian recently published a paper in JAMA on the long term cardiovascular outcomes of metabolic surgery on patients with type 2 diabetes and obesity. Dr. Aminian describes the study, primary outcomes (all-cause mortality, coronary artery events, cerebrovascular events, heart failure, nephropathy, and atrial fibrillation), results of this study, and what this means for future care of patients. Dr. Aminian also reviews who is a candidate for this type of surgery, types of bariatric surgery, risks and benefits of surgery, and factors leading to lifelong success.

Dr. Steven Nissen, Chief Academic Officer, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute discusses the benefits of metabolic (also called bariatric) surgery with surgeon Ali Aminian from the Bariatric and Metabolic Institute. Dr. Aminian recently published a paper in JAMA on the long term cardiovascular outcomes of metabolic surgery on patients with type 2 diabetes and obesity. Dr. Aminian describes the study, primary outcomes (all-cause mortality, coronary artery events, cerebrovascular events, heart failure, nephropathy, and atrial fibrillation), results of this study, and what this means for future care of patients. Dr. Aminian also reviews who is a candidate for this type of surgery, types of bariatric surgery, risks and benefits of surgery, and factors leading to lifelong success.

Dr. Steven Nissen, Chief Academic Officer, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute talks with Dr. Jerry Estep, Section Head of the George M. and Linda H. Kaufman Center for Heart Failure Treatment and Recovery and Brad Williams Pharm D, pharmacy specialist for heart failure about drug recalls. In light of the recent ARB recalls, these three medical experts discuss the ARB recall, how to keep current with new recalls, what physicians should do when a medication has been recalled, the challenges of generic medications, alternative medications for heart failure and hypertension, and when ARBs should be used.